147 related articles for article (PubMed ID: 15329275)
1. [Expression and clinical significance of methylthioadenosine phosphorylase gene in patients with non-small cell lung cancer].
Dai WM; Li BY; Yu CH; Chu XY; Zhang KT
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):907-9. PubMed ID: 15329275
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical diagnosis of methylthioadenosine phosphorylase (MTAP) deficiency in non-small cell lung carcinoma.
Watanabe F; Takao M; Inoue K; Nishioka J; Nobori T; Shiraishi T; Kaneda M; Sakai T; Yada I; Shimpo H
Lung Cancer; 2009 Jan; 63(1):39-44. PubMed ID: 18555557
[TBL] [Abstract][Full Text] [Related]
3. Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC).
Schmid M; Malicki D; Nobori T; Rosenbach MD; Campbell K; Carson DA; Carrera CJ
Oncogene; 1998 Nov; 17(20):2669-75. PubMed ID: 9840931
[TBL] [Abstract][Full Text] [Related]
4. A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer.
Schmid M; Sen M; Rosenbach MD; Carrera CJ; Friedman H; Carson DA
Oncogene; 2000 Nov; 19(50):5747-54. PubMed ID: 11126361
[TBL] [Abstract][Full Text] [Related]
5. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
[TBL] [Abstract][Full Text] [Related]
6. Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma.
Hellerbrand C; Mühlbauer M; Wallner S; Schuierer M; Behrmann I; Bataille F; Weiss T; Schölmerich J; Bosserhoff AK
Carcinogenesis; 2006 Jan; 27(1):64-72. PubMed ID: 16081515
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathological significance of homeobox BP1 mRNA expression in lung cancer tissue].
Xian YS; Dang CX; Yan CX; Li HP; Fu SW; Wang ZR
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1173-5. PubMed ID: 16939914
[TBL] [Abstract][Full Text] [Related]
8. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209
[TBL] [Abstract][Full Text] [Related]
9. Novel transmembrane GTPase of non-small cell lung cancer identified by mRNA differential display.
Chung JG; Yeh KT; Wu SL; Hsu NY; Chen GW; Yeh YW; Ho HC
Cancer Res; 2001 Dec; 61(24):8873-9. PubMed ID: 11751411
[TBL] [Abstract][Full Text] [Related]
10. [Expression of methylthioadenosine phosphorylase (MTAP) gene and demethylation of its promoter in human colorectal cancer].
Dou JX; Zhang WD; Li WT; Li HL; Cai XS; Liu J
Ai Zheng; 2009 Apr; 28(4):390-4. PubMed ID: 19622299
[TBL] [Abstract][Full Text] [Related]
11. Expression of telomerase hTERT in human non-small cell lung cancer and its correlation with c-myc gene.
Geng Z; Zhang D; Liu Y
Chin Med J (Engl); 2003 Oct; 116(10):1467-70. PubMed ID: 14570602
[TBL] [Abstract][Full Text] [Related]
12. Methylthioadenosine phosphorylase deficiency in Japanese osteosarcoma patients.
Miyazaki S; Nishioka J; Shiraishi T; Matsumine A; Uchida A; Nobori T
Int J Oncol; 2007 Nov; 31(5):1069-76. PubMed ID: 17912432
[TBL] [Abstract][Full Text] [Related]
13. Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer.
Miura N; Nakamura H; Sato R; Tsukamoto T; Harada T; Takahashi S; Adachi Y; Shomori K; Sano A; Kishimoto Y; Ito H; Hasegawa J; Shiota G
Cancer Sci; 2006 Dec; 97(12):1366-73. PubMed ID: 17052260
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
15. Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma.
García-Castellano JM; Villanueva A; Healey JH; Sowers R; Cordon-Cardo C; Huvos A; Bertino JR; Meyers P; Gorlick R
Clin Cancer Res; 2002 Mar; 8(3):782-7. PubMed ID: 11895909
[TBL] [Abstract][Full Text] [Related]
16. [Northern blot analysis of nm23 gene expression in human lung cancer].
Liu L; Qin Y; Zhou Q
Zhonghua Zhong Liu Za Zhi; 1998 Sep; 20(5):342-4. PubMed ID: 10921026
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
[TBL] [Abstract][Full Text] [Related]
18. Methylthioadenosine phosphorylase inactivation depends on gene deletion in laryngeal squamous cell carcinoma.
Conde L; Vilaseca I; Alós L; Bernal-Sprekelsen M; Cardesa A; Nadal A
Histopathology; 2012 Dec; 61(6):1082-8. PubMed ID: 23020581
[TBL] [Abstract][Full Text] [Related]
19. HMGA2 overexpression in non-small cell lung cancer.
Meyer B; Loeschke S; Schultze A; Weigel T; Sandkamp M; Goldmann T; Vollmer E; Bullerdiek J
Mol Carcinog; 2007 Jul; 46(7):503-11. PubMed ID: 17477356
[TBL] [Abstract][Full Text] [Related]
20. Thymidine phosphorylase levels and dihydropyrimidine dehydrogenase levels in non-small cell lung cancer tissues.
Chujo M; Miura T; Kawano Y; Miyawaki M; Imakiire T; Hayashita Y; Kawahara K
Oncol Rep; 2006 Oct; 16(4):777-80. PubMed ID: 16969493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]